Raina D Pang1, Michael J Zvolensky2, Norman B Schmidt3, Adam M Leventhal4. 1. Department of Preventive Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA; rpang@usc.edu. 2. Department of Psychology, University of Houston, Houston, TX; Department of Behavioral Science, University of Texas MD Anderson Cancer Center, Houston, TX; 3. Department of Psychology, Florida State University, Tallahassee, FL; 4. Department of Preventive Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA; Department of Psychology, University of Southern California, Los Angeles, CA.
Abstract
BACKGROUND: Previous research suggests that females may be more motivated to smoke for negative reinforcement (NR) than males. However, it remains unclear whether gender differences in smoking outcome expectancies for negative smoking reinforcement-an important theoretical and clinical target defined as beliefs that smoking alleviates negative affect-exist above and beyond gender differences in depression and/or other outcome expectancies. METHODS: Relations between gender and negative smoking reinforcement expectancies were examined in two independent samples. Sample 1 consisted of non-treatment seeking daily smokers (Male n = 188; Female n = 91) recruited from Southern California (49.5% Black, 32.2% Caucasian, and 18.3% other race/ethnicity). Sample 2 consisted of treatment seeking daily smokers (Male n = 257; Female n = 237) in Northern Florida and Vermont (10.7% Black, 82.9% Caucasian, and 6.4% other). RESULTS: Females (vs. males) reported stronger NR smoking expectancies with and without statistically controlling for nicotine dependence, other smoking expectancies, and anxiety and depression in both samples (βs = .06 to .14, ps = .06 to < .001). CONCLUSIONS: Beliefs that smoking alleviates negative affect may reflect a gender-specific etiological process disproportionately prominent in women. Enhancing ability to cope with negative affect without smoking or challenge NR expectancies may be particularly important for cessation treatment in women.
BACKGROUND: Previous research suggests that females may be more motivated to smoke for negative reinforcement (NR) than males. However, it remains unclear whether gender differences in smoking outcome expectancies for negative smoking reinforcement-an important theoretical and clinical target defined as beliefs that smoking alleviates negative affect-exist above and beyond gender differences in depression and/or other outcome expectancies. METHODS: Relations between gender and negative smoking reinforcement expectancies were examined in two independent samples. Sample 1 consisted of non-treatment seeking daily smokers (Male n = 188; Female n = 91) recruited from Southern California (49.5% Black, 32.2% Caucasian, and 18.3% other race/ethnicity). Sample 2 consisted of treatment seeking daily smokers (Male n = 257; Female n = 237) in Northern Florida and Vermont (10.7% Black, 82.9% Caucasian, and 6.4% other). RESULTS: Females (vs. males) reported stronger NR smoking expectancies with and without statistically controlling for nicotine dependence, other smoking expectancies, and anxiety and depression in both samples (βs = .06 to .14, ps = .06 to < .001). CONCLUSIONS: Beliefs that smoking alleviates negative affect may reflect a gender-specific etiological process disproportionately prominent in women. Enhancing ability to cope with negative affect without smoking or challenge NR expectancies may be particularly important for cessation treatment in women.
Authors: Julia D Buckner; Michael J Zvolensky; Norman B Schmidt; Kathleen M Carroll; Chris Schatschneider; Kathleen Crapanzano Journal: Addict Behav Date: 2013-10-29 Impact factor: 3.913
Authors: Adam M Leventhal; Michael Trujillo; Katherine J Ameringer; Jennifer W Tidey; Steve Sussman; Christopher W Kahler Journal: J Abnorm Psychol Date: 2014-05
Authors: Adam M Leventhal; Robert Urman; Jessica L Barrington-Trimis; Nicholas I Goldenson; Katia Gallegos; Chih Ping Chou; Kejia Wang; Kiros Berhane; Tess Boley Cruz; Mary Ann Pentz; Jennifer Unger; Rob S McConnell Journal: J Psychiatr Res Date: 2017-07-14 Impact factor: 4.791
Authors: Sarah A Bilsky; Matthew T Feldner; Ashley A Knapp; Sasha M Rojas; Ellen W Leen-Feldner Journal: Exp Clin Psychopharmacol Date: 2016-04-07 Impact factor: 3.157
Authors: Claudia G Aguirre; Mariel S Bello; Nafeesa Andrabi; Raina D Pang; Peter S Hendricks; Ricky N Bluthenthal; Adam M Leventhal Journal: Behav Modif Date: 2015-10-05
Authors: Lorra Garey; Kara Manning; Charles Jardin; Adam M Leventhal; Matthew Stone; Amanda M Raines; Raina D Pang; Clayton Neighbors; Norman B Schmidt; Michael J Zvolensky Journal: Psychol Assess Date: 2017-08-07
Authors: Tanya Smit; Lorra Garey; Kirsten J Langdon; Joseph W Ditre; Andrew H Rogers; Michael F Orr; Michael J Zvolensky Journal: Addict Behav Date: 2018-11-10 Impact factor: 3.913
Authors: Raina D Pang; Madalyn M Liautaud; Matthew G Kirkpatrick; Jimi Huh; John Monterosso; Adam M Leventhal Journal: Neuropsychopharmacology Date: 2017-09-14 Impact factor: 7.853